Lv2
110 积分 2025-01-09 加入
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
1个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
6个月前
已完结
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study
6个月前
已完结
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
7个月前
已完结
Global Burden of Major Chronic Liver Diseases in 2021
9个月前
已完结
皖公网安备34019202002308
